INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 231 filers reported holding INOVIO PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,994 | -14.0% | 131,089 | -1.3% | 0.00% | – |
| Q2 2023 | $59,316 | -91.7% | 132,846 | -84.8% | 0.00% | – |
| Q1 2023 | $717,124 | -48.5% | 874,542 | -2.0% | 0.00% | – |
| Q4 2022 | $1,392,359 | -9.4% | 892,538 | +0.2% | 0.00% | – |
| Q3 2022 | $1,536,000 | +22.8% | 890,755 | +23.1% | 0.00% | – |
| Q2 2022 | $1,251,000 | -55.4% | 723,605 | -7.3% | 0.00% | -100.0% |
| Q1 2022 | $2,802,000 | -28.3% | 780,415 | -0.4% | 0.00% | 0.0% |
| Q4 2021 | $3,910,000 | -36.9% | 783,634 | -9.4% | 0.00% | 0.0% |
| Q3 2021 | $6,194,000 | -27.3% | 865,145 | -5.8% | 0.00% | -50.0% |
| Q2 2021 | $8,517,000 | +28.2% | 918,811 | +28.4% | 0.00% | +100.0% |
| Q1 2021 | $6,643,000 | +16.3% | 715,772 | +10.9% | 0.00% | 0.0% |
| Q4 2020 | $5,710,000 | -19.7% | 645,304 | +5.2% | 0.00% | -50.0% |
| Q3 2020 | $7,114,000 | -56.4% | 613,287 | +1.3% | 0.00% | -50.0% |
| Q2 2020 | $16,320,000 | +551.2% | 605,602 | +79.8% | 0.00% | +300.0% |
| Q1 2020 | $2,506,000 | +153.6% | 336,805 | +12.5% | 0.00% | – |
| Q4 2019 | $988,000 | +28.8% | 299,407 | -20.1% | 0.00% | – |
| Q3 2019 | $767,000 | -33.0% | 374,586 | -3.7% | 0.00% | – |
| Q2 2019 | $1,144,000 | -17.8% | 389,105 | +4.3% | 0.00% | – |
| Q1 2019 | $1,392,000 | -3.6% | 372,907 | +3.3% | 0.00% | – |
| Q4 2018 | $1,444,000 | -25.3% | 360,828 | +3.8% | 0.00% | – |
| Q3 2018 | $1,933,000 | +44.8% | 347,525 | +2.0% | 0.00% | – |
| Q2 2018 | $1,335,000 | -23.6% | 340,797 | -8.1% | 0.00% | – |
| Q1 2018 | $1,747,000 | +18.6% | 371,035 | +4.0% | 0.00% | – |
| Q4 2017 | $1,473,000 | -39.2% | 356,735 | -6.7% | 0.00% | -100.0% |
| Q3 2017 | $2,423,000 | -5.1% | 382,206 | +17.4% | 0.00% | 0.0% |
| Q2 2017 | $2,552,000 | +12.6% | 325,583 | -4.9% | 0.00% | 0.0% |
| Q1 2017 | $2,266,000 | -1.2% | 342,348 | +3.6% | 0.00% | 0.0% |
| Q4 2016 | $2,294,000 | -22.9% | 330,583 | +3.5% | 0.00% | 0.0% |
| Q3 2016 | $2,977,000 | -5.1% | 319,471 | -5.9% | 0.00% | 0.0% |
| Q2 2016 | $3,138,000 | +5.2% | 339,602 | -0.8% | 0.00% | 0.0% |
| Q1 2016 | $2,982,000 | +34.8% | 342,322 | +4.0% | 0.00% | 0.0% |
| Q4 2015 | $2,212,000 | +6.8% | 329,240 | -8.2% | 0.00% | 0.0% |
| Q3 2015 | $2,072,000 | -41.1% | 358,504 | -16.8% | 0.00% | 0.0% |
| Q2 2015 | $3,515,000 | +37.4% | 430,807 | +37.4% | 0.00% | 0.0% |
| Q1 2015 | $2,558,000 | -12.2% | 313,475 | -1.2% | 0.00% | 0.0% |
| Q4 2014 | $2,913,000 | +8.2% | 317,226 | +16.1% | 0.00% | 0.0% |
| Q3 2014 | $2,693,000 | -53.0% | 273,301 | -48.4% | 0.00% | 0.0% |
| Q2 2014 | $5,724,000 | – | 529,588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Green Alpha Advisors, LLC | 570,049 | $221,749 | 0.17% |
| GMT CAPITAL CORP | 1,513,500 | $588,752 | 0.02% |
| Cedar Brook Financial Partners, LLC | 130,522 | $50,773 | 0.01% |
| Arlington Capital Management, Inc. | 27,735 | $10,789 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 296,948 | $116 | 0.01% |
| Keystone Financial Group | 109,897 | $42,751 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63,626 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 1,149,974 | $447,340 | 0.00% |
| Freedom Investment Management, Inc. | 62,298 | $24,234 | 0.00% |
| Renaissance Technologies | 4,889,500 | $1,902 | 0.00% |